当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Bashar Hanna Azar
History of lung malignant growth goes back to the mid-1400s, when the rate of death of roughly half of excavators working along the outskirt of Germany and the Czech Republic happened due to a pneumonic illness called bergkrankheit (mountain disease).1,2 Lung malignant growth is one of the most widely recognized malignancies among the industrialized countries. There are 6,000,000 new instances of lung malignancy which compares to 12.7% of the world's disease rate that were analyzed in 2008.3 For the treatment of lung malignant growth in most ideal and effective manner, early conclusion at a beginning time is the key. For early determination various modalities can be applied eg. radiology, bronchoscopy, bronchial biopsy, brushing, bronchoalveolar lavage (BAL) cytology etc.4 Bronchial biopsies can't be acted in increasingly fringe locales or in patients in danger of discharge. Bronchoscopic washing, brushing might be utilized to supplement tissue biopsies in the diagnosing lung lesions.5,6 Bronchoalveolar lavage (BAL), which was initially evolved as helpful instrument for pneumonic conditions like aspiratory alveolar proteinosis, cystic fibrosis and obstinate asthma, likewise has picked up acknowledgment and consistent ubiquity as an apparatus for diagnosing lung cancer.7 Bronchial brushing (BB) is where surface of a presumed injury, envisioned through a bronchoscope, is scratched by brush that are uncommonly intended to go through bronchoscope so as to gather the cytological example. Bronchial brushings can be utilized for exfoliative cytology or microbiological investigation. Bronchial brushings for exfoliative cytology utilize expendable cytology brush, with an indicative yield of 72% and 45%, separately, for focal and fringe lesions.8 Confirmation of the sort of lung disease by cytology is of most extreme significance before treatment can be resolved. The point of the current investigation was to contemplate the viability of bronchoalveolar lavage, bronchial brush cytology and bronchial biopsy in diagnosing lung disease. Adaptable fiberoptic bronchoscopy is regularly the underlying method for finding of lung and bronchial tumors. Numerous examinations have indicated the high precision pace of bronchial washing and brushing cytology in the assessment of neoplastic and nonneoplastic bronchopulmonary injuries.